                         SEQUENCE LISTING

<110>  IMMUNOVACCINE TECHNOLOGIES INC.
 
<120>  Methods for Potentiating an Immune Response using Depot-Forming 
       and Non-Depot-Forming Vaccines

<130>  78961-178

<150>  US 62/155,677
<151>  2015-05-01

<160>  64    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Irrelevant HLA-A2 restricted peptide

<400>  1

Ala Leu Met Glu Gln Gln His Tyr Val 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A2 restricted peptide (modified)

<400>  2

Leu Met Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV R9F peptide

<400>  3

Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Irrelevant peptide

<400>  4

Arg Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide


<400>  5

Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  6

Glu Ala Ala Gly Ile Gly Ile Leu Thr Val 
1               5                   10  


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  7

Ile Leu Thr Val Ile Leu Gly Val Leu 
1               5                   


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  8

Ala Glu Glu Ala Ala Gly Ile Gly Ile Leu 
1               5                   10  


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  9

Ala Glu Glu Ala Ala Gly Ile Gly Ile Leu Thr 
1               5                   10      


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  10

Thr Ile Leu Leu Gly Ile Phe Phe Leu 
1               5                   


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  11

Phe Leu Ala Leu Ile Ile Cys Asn Ala 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  12

Lys Thr Trp Gly Gln Tyr Trp Gln Val 
1               5                   


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  13

Ala Met Leu Gly Thr His Thr Met Glu Val 
1               5                   10  


<210>  14
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  14

Met Leu Gly Thr His Thr Met Glu Val 
1               5                   


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  15

Ser Leu Ala Asp Thr Asn Ser Leu Ala Val 
1               5                   10  


<210>  16
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  16

Ile Thr Asp Gln Val Pro Phe Ser Val 
1               5                   


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  17

Leu Leu Asp Gly Thr Ala Thr Leu Arg Leu 
1               5                   10  


<210>  18
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  18

Tyr Leu Glu Pro Gly Pro Val Thr Ala 
1               5                   


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  19

Val Leu Tyr Arg Tyr Gly Ser Phe Ser Val 
1               5                   10  


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  20

Arg Leu Pro Arg Ile Phe Cys Ser Cys 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  21

Leu Ile Tyr Arg Arg Arg Leu Met Lys 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  22

Ala Leu Asn Phe Pro Gly Ser Gln Lys 
1               5                   


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  23

Ser Leu Ile Tyr Arg Arg Arg Leu Met Lys 
1               5                   10  


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  24

Ala Leu Leu Ala Val Gly Ala Thr Lys 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  25

Ala Leu Leu Ala Val Gly Ala Thr Lys 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  26

Val Tyr Phe Phe Leu Pro Asp His Leu 
1               5                   


<210>  27
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  27

Ser Asn Asp Gly Pro Thr Leu Ile 
1               5               


<210>  28
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  28

Val Ser His Ser Phe Pro His Pro Leu Tyr 
1               5                   10  


<210>  29
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  29

Phe Leu Thr Pro Lys Lys Leu Gln Cys Val 
1               5                   10  


<210>  30
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  30

Val Ile Ser Asn Asp Val Cys Ala Gln Val 
1               5                   10  


<210>  31
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  31

His Ser Thr Asn Gly Val Thr Arg Ile Tyr 
1               5                   10  


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  32

Lys Cys Asp Ile Cys Thr Asp Glu Tyr 
1               5                   


<210>  33
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  33

Ser Ser Asp Tyr Val Ile Pro Ile Gly Thr Tyr 
1               5                   10      


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  34

Tyr Met Asp Gly Thr Met Ser Gln Val 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  35

Met Leu Leu Ala Val Leu Tyr Cys Leu 
1               5                   


<210>  36
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  36

Ala Phe Leu Pro Trp His Arg Leu Phe 
1               5                   


<210>  37
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  37

Ser Glu Ile Trp Arg Asp Ile Asp Phe 
1               5                   


<210>  38
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  38

Met Ser Leu Gln Arg Gln Phe Leu Arg 
1               5                   


<210>  39
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  39

Ser Val Tyr Asp Phe Phe Val Trp Leu 
1               5                   


<210>  40
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  40

Thr Leu Asp Ser Gln Val Met Ser Leu 
1               5                   


<210>  41
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  41

Leu Leu Gly Pro Gly Arg Pro Tyr Arg 
1               5                   


<210>  42
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  42

Ala Asn Asp Pro Ile Phe Val Val Leu 
1               5                   


<210>  43
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV T10V peptide

<400>  43

Thr Ile His Asp Ile Ile Leu Glu Cys Val 
1               5                   10  


<210>  44
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV Y10T peptide

<400>  44

Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10  


<210>  45
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV Y9T peptide

<400>  45

Tyr Met Leu Asp Leu Gln Pro Glu Thr 
1               5                   


<210>  46
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV L9V peptide

<400>  46

Leu Leu Met Gly Thr Leu Gly Ile Val 
1               5                   


<210>  47
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV T8I peptide

<400>  47

Thr Leu Gly Ile Val Cys Pro Ile 
1               5               


<210>  48
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  TRP-2 V8L peptide

<400>  48

Val Tyr Asp Phe Phe Val Trp Leu 
1               5               


<210>  49
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Wild type p53 peptide

<400>  49

Lys Tyr Met Cys Asn Ser Ser Cys Met 
1               5                   


<210>  50
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified p53 peptide

<400>  50

Lys Tyr Ile Cys Asn Ser Ser Cys Met 
1               5                   


<210>  51
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified p53-PADRE fusion peptide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa may be cyclohexylalanyl

<400>  51

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Ala Lys Tyr Ile 
1               5                   10                  15      


Cys Asn Ser Ser Cys Met 
            20          


<210>  52
<211>  429
<212>  DNA
<213>  Homo Sapiens

<400>  52
atgggtgccc cgacgttgcc ccctgcctgg cagccctttc tcaaggacca ccgcatctct       60

acattcaaga actggccctt cttggagggc tgcgcctgca ccccggagcg gatggccgag      120

gctggcttca tccactgccc cactgagaac gagccagact tggcccagtg tttcttctgc      180

ttcaaggagc tggaaggctg ggagccagat gacgacccca tagaggaaca taaaaagcat      240

tcgtccggtt gcgctttcct ttctgtcaag aagcagtttg aagaattaac ccttggtgaa      300

tttttgaaac tggacagaga aagagccaag aacaaaattg caaaggaaac caacaataag      360

aagaaagaat ttgaggaaac tgcgaagaaa gtgcgccgtg ccatcgagca gctggctgcc      420

atggattga                                                              429


<210>  53
<211>  142
<212>  PRT
<213>  Homo Sapiens

<400>  53

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             


Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
    130                 135                 140         


<210>  54
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A1 restricted peptide (native)

<400>  54

Phe Glu Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  55
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A1 restricted pepitde (modified)

<400>  55

Phe Thr Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  56
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A2 restricted pepitde (native)

<400>  56

Leu Thr Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  57
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A3 restricted peptide (native)

<400>  57

Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe 
1               5                   10  


<210>  58
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A3 restricted peptide (modified)

<400>  58

Arg Ile Ser Thr Phe Lys Asn Trp Pro Lys 
1               5                   10  


<210>  59
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A24 restricted peptide (native)

<400>  59

Ser Thr Phe Lys Asn Trp Pro Phe Leu 
1               5                   


<210>  60
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-B7 restricted pepitde (native)

<400>  60

Leu Pro Pro Ala Trp Gln Pro Phe Leu 
1               5                   


<210>  61
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-helper epitope A16L from tetanus toxin

<400>  61

Ala Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210>  62
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-helper epitope PADRE


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa may be cyclohexylalanyl

<400>  62

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  63
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  T-helper epitope F21E from tetanus toxin

<400>  63

Phe Asn Asn Phe Thr Val Ser Phe Trp Leu Arg Val Pro Lys Val Ser 
1               5                   10                  15      


Ala Ser His Leu Glu 
            20      


<210>  64
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CpG oligonucleotide

<400>  64
tccatgacgt tcctgacgtt                                                   20


